Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. Chalmers JD, Haworth CS, Metersky ML, Loebinger MR, et al. N Engl J Med 2020 Sep 7. doi: 10.1056/NEJMoa2021713.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chalmers JD, Haworth CS, Metersky ML, Loebinger MR, et al. Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. N Engl J Med 2020 Sep 7. doi: 10.1056/NEJMoa2021713.
PMID: 32897034